Eric Coldwell Analyst PerformanceManaging Director at Robert W. BairdEric Coldwell is a stock analyst at Robert W. Baird focused in the medical sector, covering 19 publicly traded companies. Over the past year, Eric Coldwell has issued 33 stock ratings, including buy and hold recommendations. While full access to Eric Coldwell's proprietary MarketBeat Analyst Rating is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Eric Coldwell's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Ratings, Coverage, and Performance StatisticsAnalyst RatingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings65 Last 9 YearsBuy Recommendations52.46% 32 Buy RatingsCompanies Covered19 Unique Companies Ratings Distribution61RatingsDistribution of strong buy, buy, hold, and sell ratings by Eric Coldwell.RatingPercentageCount Strong Buy0.0%0 ratings Buy52.5%32 ratings Hold47.5%29 ratings Sell0.0%0 ratingsOut of 61 total stock ratings issued by Eric Coldwell at Robert W. Baird, the majority (52.5%) have been Buy recommendations, followed by 47.5% Hold.Best & Worst CallsBest Call000.0%SYNHFeb 2018Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%SNCEApr 2022Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ52.6% of companies on NASDAQ10 companiesNYSE47.4% of companies on NYSE9 companiesEric Coldwell, an analyst at Robert W. Baird, currently covers 19 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical17 companies89.5%Retail/Wholesale1 company5.3%Miscellaneous1 company5.3%Eric Coldwell of Robert W. Baird specializes in stock coverage within the Medical sector, with additional focus on Retail/Wholesale and companies.Coverage IndustriesIndustryPercentageMEDICAL SERVICES7 companies36.8%MED/DENTAL - SUPP2 companies10.5%MED PRODUCTS2 companies10.5%MED - BIOMED/GENE1 company5.3%MED - OUTP/HM CRE1 company5.3%MED INSTRUMENTS1 company5.3%HEALTH INFORMATION SERVICES1 company5.3%RETAIL - DRUG STR1 company5.3%DIAGNOSTICS & RESEARCH1 company5.3%DRUG STORES & PROPRIETARY STORES1 company5.3%Miscellaneous1 company5.3% About Eric ColdwellEric Coldwell is a Baird senior analyst covering Healthcare Supply Chain & Pharma Services. Prior to joining Baird in 2003, he was a senior analyst at Prudential Securities and Wachovia Securities. In 2016, Eric was ranked by Thomson Reuters (StarMine) as the No. 1 stock picker in Life Sciences Tools & Services. In 2015, he was ranked by StarMine as the No. 1 earnings estimator in Health Care Technology, and the No. 1 earnings estimator and No. 3 stock picker in Life Sciences Tools & Services. In 2014, Eric was ranked by StarMine as the No. 1 stock picker in Healthcare Providers & Services and the No. 2 earnings estimator in Healthcare Technology. He received six additional StarMine awards prior to 2014 and is a three-time recipient of The Wall Street Journal's "Best on the Street" designation. Eric received a BA in Political Science from Wake Forest University and an MBA with a concentration in Finance from Queens University.Follow on LinkedIn Eric Coldwell's Ratings History at Robert W. Baird Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export to Excel CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsFTREFortrea9/3/2025Boost Price Target$10.01$14.00Outperform$0.0000.00% ROIICLRIcon9/2/2025Boost Price Target$176.22$224.00Outperform$0.0000.00% ROILHLabcorp8/25/2025Set Price Target$277.51$311.00$0.0000.00% ROIDGXQuest Diagnostics8/25/2025Reiterated Rating$180.10$194.00Neutral$0.0000.00% ROIPINCPremier8/20/2025Boost Price Target$26.21$27.00Neutral$0.0000.00% ROICAHCardinal Health8/13/2025Boost Price Target$146.51$203.00Outperform$0.0000.00% ROIOMIOwens & Minor8/12/2025Lower Price Target$4.65$7.00Outperform$0.0000.00% ROIOMIOwens & Minor8/8/2025Set Price Target$7.06$10.00$0.0000.00% ROIFTREFortrea8/4/2025Upgrade$5.46$9.00Outperform$0.0000.00% ROILHLabcorp7/25/2025Boost Price Target$267.42$302.00Outperform$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. ICLRIcon7/24/2025Upgrade$167.89$224.00Outperform$0.0000.00% ROIMEDPMedpace7/23/2025Boost Price Target$477.73$490.00Neutral$0.0000.00% ROIIQVIQVIA7/23/2025Boost Price Target$187.89$196.00Neutral$0.0000.00% ROIOMIOwens & Minor6/6/2025Boost Price Target$7.85$10.00Neutral$0.0000.00% ROIPINCPremier5/15/2025Boost Price Target$22.67$22.00Neutral$0.0000.00% ROICRLCharles River Laboratories International5/8/2025Boost Price Target$136.43$140.00Neutral$0.0000.00% ROIIQVIQVIA5/7/2025Lower Price Target$152.78$161.00Neutral$0.0000.00% ROIICLRIcon5/2/2025Lower Price Target$145.21$160.00Neutral$0.0000.00% ROICAHCardinal Health5/2/2025Boost Price Target$145.46$170.00Outperform$0.0000.00% ROILHLabcorp4/30/2025Boost Price Target$236.66$267.00Outperform$0.0000.00% ROIDGXQuest Diagnostics4/23/2025Boost Price Target$172.56$194.00Outperform$0.0000.00% ROIMEDPMedpace4/23/2025Lower Price Target$282.28$313.00Neutral$0.0000.00% ROIDGXQuest Diagnostics3/20/2025Boost Price Target$166.64$191.00Outperform$0.0000.00% ROIICLRIcon3/4/2025Lower Price Target$182.55$203.00Neutral$0.0000.00% ROIOMIOwens & Minor3/3/2025Boost Price Target$9.56$11.00Neutral$0.0000.00% ROIAHCOAdaptHealth2/27/2025Boost Price Target$11.10$16.00Outperform$0.0000.00% ROIOMIOwens & Minor2/25/2025Lower Price Target$6.39$10.00Neutral$0.0000.00% ROICRLCharles River Laboratories International2/20/2025Lower Price Target$165.00$173.00Neutral$0.0000.00% ROIPINCPremier2/5/2025Lower Price Target$18.81$19.00Neutral$0.0000.00% ROIOMIOwens & Minor2/4/2025Lower Price Target$9.23$14.00Neutral$0.0000.00% ROIDGXQuest Diagnostics1/31/2025Set Price Target$172.44$189.00$0.0000.00% ROIMEDPMedpace1/27/2025Boost Price Target$350.14$362.00Neutral$0.0000.00% ROIIQVIQVIA1/21/2025Lower Price Target$197.25$210.00Neutral$0.0000.00% ROI Stock Forecasts and Research Tools Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
